Aptus Pharma Approves ₹44.73 Crore Preferential Equity Allotment
Aptus Pharma Ltd · Outcome · 12 Nov 2026, 6:17 pm
Aptus Pharma Approves ₹44.73 Crore Preferential Equity Allotment Aptus Pharma Limited approved the preferential allotment of 15,97,470 equity shares at an issue price of ₹280 per share (face value ₹10 plus ₹270 premium) on 12th Nov'26, raising ₹44.73 crore across 188 allottees for cash. Consequently, paid-up equity capital increased from ₹17.15 crore (1.715 crore shares) to ₹18.75 crore (1.875 crore shares). The allotment follows shareholder approval on 14th Sep'26 and BSE in-principle approval on 30th Oct'26, adjusted from an initial 16.03 lakh shares due to non-subscription by two proposed allottees.
Original exchange filing (PDF)
More announcements from Aptus Pharma Ltd
- Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve Intimation of Board Meeting for .... · 06 Nov 2026
- Receipt of In-Principle Approval for Preferential Issue · 31 Oct 2026
- Transcript for Earning Call for the Quarter and Half Year ended on September 30, 2026 · 30 Oct 2026
- Audio recording of the Earnings Call dated October 26, 2026 · 27 Oct 2026
- Intimation of Investor Presentation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 · 23 Oct 2026
- Intimation of Earnings Call for the quarter and half year ended September 30, 2026 · 26 Oct 2026
- Pursuant to Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company .... · 21 Oct 2026
- Pursuant to Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company .... · 21 Oct 2026
